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Abstract.  Addition of the bioactive phospholipid 
lysophosphatidic acid (LPA) or a thrombin  recep- 
tor-activating peptide (TRP) to serum-starved N1E-115 
or NG108-15 neuronal cells causes rapid growth cone 
collapse, neurite retraction,  and transient rounding of 
the cell body. These shape changes appear to be 
driven by receptor-mediated contraction of the cortical 
actomyosin system independent of classic second mes- 
sengers.  Treatment of the cells with Clostridium botu- 
linum C3 exoenzyme, which ADP-ribosylates and 
thereby inactivates the Rho small GTP-binding pro- 
tein,  inhibits LPA- and TRP-induced force generation 
and subsequent shape changes.  C3 also inhibits  LPA- 
induced neurite retraction in PC12 cells. Biochemical 
analysis reveals that the ADP-ribosylated substrate is 
RhoA.  Prolonged C3 treatment of cells maintained in 
10%  serum induces the phenotype of serum-starved 
cells, with initial cell flattening being followed by neu- 
rite outgrowth;  such C3-differentiated cells fail to re- 
tract their neurites in response to agonists.  We con- 
clude that RhoA is essential for receptor-mediated 
force generation and ensuing neurite retraction in N1E- 
115 and PC12 cells, and that inactivation of RhoA by 
ADP-ribosylation abolishes actomyosin contractility 
and promotes neurite outgrowth. 
T 
hE  Ras superfamily of low molecular weight GTP- 
binding proteins can be divided into three major sub- 
families, i.e., Ras, Rab, and Rho (Bourne et al., 1990; 
Hall,  1990).  The most studied of these proteins,  Ras,  can 
cause cell transformation  and triggers a serine/threonine  pro- 
tein kinase cascade in growth factor-stimulated cells (e.g., 
Leevers and Marshall,  1992; Moodie et al., 1993; Warne et 
al., 1993; Hordijk et al., 1994). In PC12 cells, Ras is an es- 
sential  component of nerve growth factor (NGF)l-induced 
signaling and differentiation  (Noda et al., 1985; Bar-Sagi et 
al., 1985; Hagag et al., 1985; Qiu and Green, 1991; Thomas 
et al.,  1992; Wood et al.,  1992; Li et al.,  1992).  The Rab 
proteins,  on the other hand, are thought to be involved in in- 
tracellular vesicular transport (Balch,  1990) and have been 
implicated in neurotransmitter release from the presynaptic 
terminal (Fischer von Mollard et al., 1990; Mizoguchi et al., 
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1. Abbreviations  used in this paper: LPA, lysophosphatidic  acid; MLC(K), 
myosin light chain (kinase); NGF, nerve growth factor; TRP, thrombin re- 
ceptor-activating pepfide. 
1990;  Shirataki  et al.,  1993).  The  function  of the three 
identified Rho proteins (RhoA, RhoB, and RhoC) have been 
explored by the use of Clostridium botulinum C3  exoen- 
zyme, which ADP-ribosylates Rho in its putative effector do- 
main and thereby inactivates  the protein (Aktories et al., 
1987;  Sekine et al.,  1989;  Paterson et al.,  1990).  These 
studies  have  revealed  that  Rho  regulates  the  actin-based 
cytoskeleton and thereby participates  in the control of cell 
shape,  agonist-induced  cell adhesion  and motility,  smooth 
muscle contraction and cell cycle progression (for review see 
Hall, 1992; Narumiya and Morii, 1993). Although the Rho 
proteins are highly expressed in brain and enriched in synap- 
tosomes (Morii et al.,  1988; Kim et al.,  1989),  there are 
hardly any clues to their neural  functions. 
We and others recently reported that  in  serum-starved 
N1E-115 and NG108-15 neuronal  ceils, the bioactive phos- 
pholipid lyophosphatidic  acid (LPA) (Moolenaar,  1994) and 
a thrombin receptor-activating peptide induce rapid growth 
cone collapse, neurite retraction, and transient  rounding  of 
the cell body, apparently through  receptor-mediated con- 
traction of the actin-based cytoskeleton (Jalink  and Moo- 
lenaar,  1992; Suidan et al., 1992; Jalink et al., 1993; Smal- 
heiser,  1993).  Serum, which contains albumin-bound LPA 
(Tigyi and Miledi,  1992; Eichholtz  et al.,  1993) also pro- 
voked  neurite  retraction  in  nerve  growth  factor  (NGF)- 
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1992; Tigyi and Miledi, 1992) and in serum-starved mouse 
neuroblastoma cells (Seeds et al.,  1970). Furthermore, se- 
rum inhibits  neurite outgrowth  in various types of primary 
neuronal  cultures,  an effect presumably caused by albumin- 
bound LPA (Adler, 1982; Skaper et al., 1983; Ziller and Le 
Douarin,  1983; Davis et al., 1984; Windebank and Blexrud, 
1986;  Dyer et al.,  1992;  Tigyi and Miledi,  1992).  These 
findings support the view that both LPA and thrombin may 
play a normal physiological  role in neural morphogenesis, 
development,  and plasticity and  a pathophysiological  role 
during traumatic  injury of the nervous system when neurons 
are acutely exposed to blood-borne factors such as thrombin 
and LPA, and often undergo irreversible degeneration  (Haw- 
kins and Seeds, 1986; Monard,  1988; Grand et al.,  1989; 
Jalink et al.,  1993, and references  therein). 
In previous studies we have explored the mechanisms  by 
which thrombin and LPA exert their dramatic effects on neu- 
ral cell shape  (Jalink  and Moolenaar,  1992; Jalink  et al., 
1993). We have identified the putative LPA receptor by pho- 
toaffinity labeling and found that it is prominently expressed 
in brain as well as in N1E-115 and NG108-15 cells (van der 
Bend et al., 1992). We have demonstrated that both LPA and 
thrombin act through their cognate G protein-coupled recep- 
tors to rapidly reorganize the cortical actin cytoskeleton via 
a novel signaling pathway that is independent  of prior Ca  2+ 
mobilization,  protein kinase  C activation  or altered cAMP 
levels. Instead, LPA- and thrombin-induced  shape changes 
of N1E-115 cells are coincident with a small but significant 
increase  in  p60  ~  tyrosine kinase  activity  (Jalink  et  al., 
1993). LPA-induced actin reorganization  is also observed in 
fibroblasts:  Ridley and Hall (1992) reported that LPA, like 
serum, triggers  the formation  of focal adhesions  and stress 
fibers in serum-starved 3T3 cells and that this action is medi- 
ated by the Rho protein. 
In this paper we have examined the possible role of Rho 
in agonist-induced  shape changes in N1E-115 and PC12 cells. 
We show that  C3  treatment  inhibits  LPA- and  thrombin- 
induced  generation  of actomyosin-based contractile  forces 
and thereby prevents  neurite retraction and cell rounding. 
Furthermore,  C3 treatment  of exponentially  growing  cells 
causes prominent neurite outgrowth accompanied by growth 
arrest.  Our results  suggest a key role for the RhoA protein 
in  the  regulation  of neural  architecture  by  extracellular 
agonists. 
Materials and Methods 
Materials 
L-c~-lysophosphatidic  acid  (1-oleoyl)  was  obtained  from  either  Sigma 
Chemical Co. (St. Louis, MO) or Serdary Research Laboratories (London, 
Ontario), and bovine thrombin was from Sigma Chemical Co. Thrombin 
receptor-activating  pepfide (TRP, sequence SFLLRNPDKYEPF; Vu et al., 
1991) was synthesized as described (Jalink and Moolennar,  1992). Recom- 
binant C  botulinum C3 e~oenzyme  was prepared essentially  as described 
(Nemoto et al.,  1991). Pertussis toxin was from List Biological Laborato- 
ries Inc. (Campbell, CA). NGF was obtained from Collaborative Research 
Inc.  (Bedford,  MA) and KT5926  from Caibioehem-Behring Corp.  (San 
Diego, CA). Phallacidin labeled with fluorescent NBD [N-(7-nitrobenzo-2- 
oxa-l,3-diazole)]  (NBD-phallacidin)  and Indo-1 acetoxymethylester  were 
from Molecular Probes (Eugene,  OR).  Phenyl-methyl-sulfonyl-fluoride, 
soybean  trypsin inhibitor, and laminin were from Sigma Chemical Co.; 
leupeptin was from Boehringer Mannheim Gmbtt (Mannheim, Germany); 
aprotinin from Fluka Chemie (Brussels,  Belgium); trichloroacetic acid and 
EGTA were from Merck (Darmstadt, Germany); and DME, penicillin, and 
streptomycin  from GIBCO BRL Life Teeimols Inc. (Gaithersburg, MD). 
[32p]NAD and [32p]orthophosphate  were obtained from Amersham. Cul- 
ture disposables  were from Becton Dickinson & Co. (Plymouth, England). 
Cell Culture 
N1E-115 mouse neuroblastoma cells (Amano et al.,  1972) and NG108-15 
glioma x  neuroblastoma hybrid cells (Hamprecht et al.,  1985) were rou- 
tinely grown in DMEM supplemented with penicillin (100 t~g/ml), strep- 
tomycin (100/~g/mi),  and 10% FCS, For morphological  assays, cells (pas- 
sage 8 to 25) were seeded at a density of 1-2  x  llY/cm 2 in plastic 35-ram 
dishes and 24--48 h later they were exposed to serum-free DME for 20-24 h. 
PC12 cells were seeded at l0  s cells/35-mm dish and grown in DME sup- 
plemented with  10%  FCS  and 5%  horse serum.  For neurite retraction 
studies, PC12 cells were cultured in serum-free chemically defined medium 
(Skaper et ai., 1983) containing NGF (25 ng/ml) for 2 d. Under these condi- 
tions, 70-80% of the cells developed  neurites of 15-30 ~m in length (cf. 
Dyer et al.,  1992). 
Cell Fractionation and I~2P]ADP  Ribosylation 
Cells were grown in 10-cm culture dishes for 24 h, washed twice with PBS, 
scraped with a rubber policeman in ice-cold 20 mM Tris/HCl (pH 8.0) in 
the presence ofprote,  ase inhibitors (0,4 mM PMSE 20 ttM leupeptin, 0.005 
trypsin inhibiting U/ml aprotinin, 2/zg/ml soybean trypsin inhibitor), and 
homogenized with 30 strokes (tight pestle) in a 10-ml Douncer.  Cell debris 
was discarded by eentrifugation (500 g for 10 rain) at 4"C. The supernatants 
were centrifuged at 25,000 g for 30 rain to separate the cytosolic  from the 
crude membrane fraction. Protein was determined with the Bradford assay 
(Bio-Rad  Laboratories, Cambridge, MA; see Bradford,  1976).  For ADP 
ribosylation  assays, membrane or cytosolic fractions (•30  t~g protein) were 
heat inactivated at 650C for 5 rain and then taken up in reaction buffer con- 
taining: 90 mM Tris/HCl (pH 8.0), 2.6 mM MgC12, 1 mM EDTA,  10 mM 
thymidine, 10 mM dithiothreitoI, 1 mM ATP, 100 txM GTP,  10 i~Ci/rni 
[32p]NAD. The  reaction  was  started by addition of C3  exoenzyme  (5 
#g/ml) or pertussis toxin (1/~g/ml). After 60 rain at 37°C, the reaction was 
stopped by addition of ice-cold IV_A (10% wt/vol).  IV_A was removed by 
centrifugafion  (15,000 g for 15 rain) and washing the pellets with ether. Af- 
ter gel electrophoresis (using 12 % polyacrylamide),  ADP-ribosylated  pro- 
teins were  visualized  by autoradiography (Kodak  XAR film).  For two- 
dimensional gel analysis, the isoelectric  focusing gels contained pH 3.5-10 
ampholines (LKB Instruments, Bromma, Sweden) and the second dimen- 
sion gels  12% acrylamide. 
Morphological Analysis 
Agonist-induced  shape changes of N1E-115 or NG108-15 cells were scored 
as described previously (Jalink and Moolanaar,  1992). In brief, low-density 
cultures in 35-ram dishes were shifted to serum-free DME for 20-30 h to 
obtain a nearly homogeneous population of flattened cells in which 90-95 % 
of the cells have short filopodia and 5-10% of the cells have developed hen- 
rites of >25/zm in length. Alternatively,  cells were maintained for 4--5 d 
in serum-free DME to obtain a more fully differentiated cell population in 
which  virtually  all  cells  have  well-developed,  long  neurites.  Agoulst- 
induced  shape  changes were  monitored  using  an  inverted microscope 
(Nikon Diaphot) equipped with phase-contrast optics and a video recording 
system.  Experiments were  performed at 37°C  in bicarbonate/5% CO~- 
buffered DME, pH 7.3. Cells were photographed prior to and 3 rain after 
addition  of  agents  using  a  Sony  UP-850  videoprinter.  To  determine 
dose-response relationships,  cell morphology was assessed  semi-quantita- 
tively at 3 rain after agonist addition. Relative  shape change (~% shape 
change") was defined as follows (Jalink'and Moolenaar,  1992; Jalink et al., 
1993): 0%, no detectable change in any cell (20-40 single cells within a 
microscopic field);  100%, complete rounding up of all flattened cells; 50%, 
all cells display partially (uhalf") rounded shape. Intermediate values were 
estimated by interpolation.  In large series of experiments,  assessment of cell 
rounding from photomicrographs by a second person with no prior knowl- 
edge of the experimental protocol, yielded data that did not deviate by more 
than 10%.  Data are presented as means +  SEM (n >  3). 
Cell viability before and after treatment with the various agents was not 
detectably affected as determined by trypan blue exclusion.  However, after 
prolonged serum deprivation (6-7 d), differentiated NIE-115 cells begin to 
die by apoptosis (Kruman et al.,  1993). 
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Various  methods have been  described  to demonstrate  contractile  forces  in 
individual  cells.  Shear  forces  generated  by  migrating  fibroblasts  can  cause 
visible  wrinkling  of  ultrathin  sheets  consisting  of  polymerized dimethyl- 
polysiloxane  (Harris  et  al.,  1980;  Baorto  et  al.,  1992).  Alternatively,  bend- 
ing  of  highly  flexible  microneedles  has  been  used  to  measure  forces  gener- 
ated  by growing neurites  (Dennerl  et al.,  1988). However, our ~rts  to 
adopt either of both methods were unsuccessful. N1E-115 cells were found 
to be incapable  of inducing visible wrinkles  in laminin-coated  layers of 
polymerized dimethylpolysiloxane (viscosity: 600 Stokes), presumably be- 
cause of insufficient cell-substratum  adhesiveness.  Using the flexible nee- 
die approach for monitoring the build-up of contractile forces, results were 
highly  variable  between  different  experiments  and  neurites  were often 
damaged by the microneedle.  Moreover, the latter technique is not readily 
compatible with the focai application  of ngonists from a micmpipette. 
We therefore developed an alternative method to monitor the generation 
of contractile  forces  in the neurite  shafts.  In this  new assay, we either 
selected cells with "loose" neurites that adhere to the dish only at the cell 
soma and the growth cone, or else we deliberately detached neurites from 
the substratum using a sharp microncedle fixed on a micromanipulator.  A 
thin plastic suction pipette (oo25-ttm diam) was then positioned at one side 
of the neurite shaft and a local, continuous flow of medium was then gener- 
ated by suction to provoke bending of the loose neurite.  A second pipette 
(~2-t~m tip size) containing agonist was positioned opposite to the suction 
pipette,  close  to the  neuritc  under  study.  Agonists  were  pressure  applied  and 
neurite  morphology was monitored for  a period  of  at  least  10 min. This 
technique has the advantage of local perfusion:  agents are rapidly removed 
by the suction pipette,  thus allowing successive experiments to be carried 
out on different neurite-bcaring cells in the same dish. Shape changes were 
video recorded and photographed  using a videoprinter.  Statistical signifi- 
cance was calculated using the Kolmngorov/Smimov parameter-free test for 
differences between two samples. 
F-Actin Staining 
Cells grown on circular cover glasses were fixed for 5 min with 3 % parafor- 
maldehyde in PBS followed  by  permeabilization using PBS containing 0.1% 
Triton X-100 and 1 mM EGTA for 5 rain. After rinsing the cells in EGTA- 
containing PBS, NBD-phallacidin (2 ng/ml) was added for 20 rain at room 
temperature. Cells were viewed using a Bio-Rnd/Nikon confocal laser scan- 
ning microscope. 
[Ca2+]~  Measurements 
Serum-deprived cells, attached to glass cover slips (3 ×  1 cm), were loaded 
with indo-1 by exposing them to 5 #M indo-l-acetoxymethylester for 30 min 
at 370C. Fluorescence measurements were carried out as described (Jalink 
et al., 1990). 
Activation of  p21 ~ 
Serum-starved  cells in  six-well plates  (one  well,  10  cm  2)  were  serum 
starved for 20 h and then exposed to phosphate-free  DME supplemented 
with 200 t~Ci [32p]i per well for an additional 4 h. Cells were treated with 
agonist, lysed in a 1% Triton X-114 Hepes buffer, and t)21  ru was immuno- 
precipitated,  and then assayed for bound nu¢leotides by thin layer chroma- 
tography  as described  (van Corven et al.,  1993). 
Results 
ADP Ribosylation of  Rho Proteins in NIE-115 Cells 
by C3 Exoenzyme 
When membranes and cytosol from either N1E-115 cells or 
Rat-1 fibroblasts are ADP-ribosylated by C3 exoenzyme and 
subjected  to  SDS-PAGE,  a  distinct  p2p]ADP-ribosylated 
protein band of"o  23 kD is detected (Fig. 1 A). N1E-115 cells 
showed  consistently  stronger  riP-labeling  in  the  cytosol 
than  in  the  membrane  fraction,  in  agreement  with  the 
reported subcellular distribution of p21 ~  (Narumiya et al., 
1988; Adamson et al., 1992),  whereas about equal amounts 
Figure  1.  [32p]ADP-ribosylation  of  23-kD  protein  by  C3  exo- 
enzyme in Rat-1  and N1E-115  cells.  (A) Cytosol and crude mem- 
branes  were  ADP-ribosylated  using  [32P]NAD  as  described  in 
Materials and Methods.  (B) In situ ADP-ribosylation in N1E-I15 
cells by C3 treatment (30 #g/ml; 4-h preincubation) of intact cells. 
Cells were then homogenized and cytosol and membrane fractions 
used for ADP ribosylation. (m, membranes; c, eytosol). (C) Two- 
dimensional  polyacrylamide  gel  analysis  of proteins  [32p]ADP- 
ribosylated by C3 in cell lysates from N1E-115  cells. Cell homog- 
enization and ADP-ribosylation of proteins by C3 was carried out 
as described in Materials and Methods. The reaction mixture was 
solubilized in sample buffer, separated by IEF (ampholines 3.5--10), 
and then by SDS-PAGE on 12 % acrylamide gels. The small circular 
spot (,020 kD) at pH 6.3  is also observed in control samples (in 
the absence of C3)  and hence is not a C3 substrate. 
of radioactivity were found in the membrane and cytosolic 
fraction from Ratq  cells. To identify the C3 substrate(s)  in 
further detail we performed two-dimensional gel analysis of 
ADP-ribosylated protein extracts  from N1E-115 cells (Fig.  1 
Jalink et al. Rho and Receptor-mediated Neural Shape Changes  803 Figure 2. Effect  of C3 on agonist-induced shape changes in N1E-115 cells. (A) Morphology of N1E-115 cells maintained in serum-free 
medium for 24 h. (B) Response of the cells in A to treatment with LPA (1 #M) for 3 min. (C) Serum-deprived cells pretreated with C3 
(30 #g/ml) for 3 h. (D) Response of the ceils in C to treatment with LPA (1 #M) for 3 min. Note absence of morphological changes in 
C3-treated cells. Similar results were obtained with NG108-15 cells. Bar, 40 #m. 
C). This analysis reveals that the major 21-23 kD C3 sub- 
strate migrates between pH 5.9 and 6.2, which identifies this 
protein as being RhoA (pI 6.1, as opposed to 5.3 for RhoB 
and 6.8 for RhoC; Yeramian et al.,  1987; Nemoto et al., 
1992).  Overexposure of the film reveals an additional minor 
C3 substrate, migrating at pH >8 and with an apparent mo- 
lecular mass of 22 kD (Fig.  1 C).  This minor spot most 
likely is the Rho-related Rac protein, which has a pI of 8.5 
(Didsbury et al., 1989) and serves only as a very poor sub- 
strate for C3  ADP-ribosyltransferase in vitro (Just et al., 
1992; Ridley and Hall,  1992);  when introduced into living 
cells, C3 specifically inhibits Rho-dependent, but not Rac- 
dependent  events  (Ridley  and  Hall,  1992).  From  these 
results we conclude that the RhoA protein is by far the pre- 
dominant C3 substrate in N1E-115 cells. 
When N1E-115 cells were pretreated with 30 #g/ml C3 for 
4 h and then homogenized and fractionated followed by ADP 
ribosylation, the amount of Rho protein available for subse- 
quent in vitro [32P]ADP-ribosylation  by C3 is strongly re- 
duced (Fig.  1 B). Thus, RhoA has undergone almost com- 
plete ADP-ribosylation in situ during several  hours of C3 
treatment. 
Effect of C3 on Agonist-induced Shape Changes 
Addition of LPA, serum (which contains I-5/zM LPA; Eich- 
holtz et al.,  1993),  thrombin or TRP (Vu et al.,  1990)  to 
serum-deprived N1E-115 or NG108-15 cells causes immedi- 
ate, dramatic morphological changes (Jalink et al.,  1992, 
1993; see also Suidan et al., 1992). Within seconds of  agonlst 
addition, growth cones collapse, developing neurites retract 
and flattened cell bodies start to round-up (Fig. 2, A and B). 
Rounding up of somata is usually complete within 1 min, 
while complete retraction of lengthy neurites can last for up 
to 30 min in the continuous presence of agonist; shrunken 
neurite.s often undergo visible degeneration, whereas rounded 
cell bodies gradually reflatten in the continuous presence of 
agonist (Jalink et al.,  1992,  1993). 
Pretreatment of serum-starved N1E-115 cells with C3 for 
several hours markedly inhibits LPA- and thrombin-induced 
shape changes (Fig. 2, C and D) which correlates with in situ 
ADP-ribosylation of RhoA (Fig.  1 B). The etfeet of C3 is 
dose and time dependent, with almost complete inhibition 
observed at 30 gg/ml C3 after a 3-h incubation (Fig. 3). Inhi- 
bition was not reversed by washing the C3-treated cells. Of 
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Figure 3.  Dose dependence of shape change inhibition by C3 in 
N1E-115 ceils. Cells were treated for 3 h with the indicated concen- 
trations of C3, exposed to LPA for 3 rain and the ensuing shape 
change assessed as described in Materials and Methods. 
note, there are no significant differences in ceil shape be- 
tween control ceils and cells treated with C3 for 3 h in serum- 
free medium (cf. Fig. 2, A and C).  This contrasts to the 
behavior of fibroblasts, which rapidly round up after intro- 
duction of C3 (Chardin et al., 1988; Paterson et al., 1990). 
Serum and LPA also promote neurite retraction in primary 
neurons and NGF-treated PC12 ceils, respectively (see In- 
troduction for references),  Generally, PC12  cells respond 
more slowly to LPA and serum than N1E-115 cells, with the 
first signs of neurite retraction being detectable after 5-10 
min  rather  than  seconds  (Dyer  et  al.,  1992;  Tigyi and 
Miledi, 1992; Jalink, K., unpublished observations). Prein- 
cubation of NGF-treated PC12 cells with C3 (30 #g/rnl for 
3 h) largely inhibits LPA- and serum-induced neurite retrac- 
tion (not shown), demonstrating that the effects of C3  on 
agonist-induced neurite retraction is not restricted to N1E- 
115 cells. From these results we conclude that RhoA function 
is essential for agonist-induced neurite retraction and cell 
rounding. 
Effects of C3 on the Actin Cytoskeleton 
We next examined the effects of C3 on the actin cytoskeleton 
in serum-starved N1E-115 cells. Like most neuronal cells, 
N1E-115  and  NG108-15  cells  do  not possess  actin  stress 
fibers extending throughout the cytoplasm but instead show 
f-actin staining in the cell periphery only, particularly in 
filopodia and growth cones (Jalink and Moolenaar, 1992; Ja- 
link et al., 1993).  Fig. 4 shows the distribution of f-actin in 
control NIE-115 cells, LPA-treated cells, and cells pretreated 
with 30 #g/ml C3 for 3 h and then challenged with LPA. As 
shown earlier for thrombin (Jalink and Moolenaar,  1992), 
LPA triggers the rapid formation of a "contractile ring" of 
f-actin  just underneath the plasma membrane (Fig. 4 B). C3- 
treated cells remain flattened and resist LPA action, but it is 
seen that they display somewhat reduced f-actin staining in 
the filopodia and the cell cortex when compared to control 
cells (el. Fig. 4, A and C). 
Figure 4. F-actin staining in serum-starved N1E-115 cells. (A) Flat- 
tened cell deprived from serum for 24 h. (B) Rounded, "contracted" 
cell treated with LPA for 3 rain. (C) Cell pretreated with C3 for 
3 h; subsequent treatment with LPA or thrombin left morphology 
unaltered (not shown). Note diminished f-actin staining in C3- 
treated cell as compared to control ceil  (,4). Ceils were fixed, 
stained with NBD-phallacidin and viewed by confocal microscopy 
as described in Materials and Methods. Bar, 20/zm. 
C3 Blocks Generation of  Actomyosin-based 
Contractile Forces 
We previously suggested that LPA- and thrombin-induced 
cell rounding and neurite retraction is secondary to contrac- 
tion of  the cortical actin.cytoskeleton  (Jalink and Moolenaar, 
Jalink et al. Rho and Receptor-mediated Neural Shape Changes  805 Figure  5.  Agonist-induced 
contraction of detached neu- 
rites.  (,4) Schematic illustra- 
tion  of experimental proce- 
dure. A flow of test medium 
was generated by a suction pi- 
peue (S) positioned close to a 
loose neurite (detached from 
the dish between the arrows), 
causing the neurite to bend. 
Agonists were applied from a 
micropipette  (,4). (B)  De- 
tached neurite under control 
conditions. (C) Neurite bend- 
ing  provoked  by  flow  of 
medium.  (D)  Contraction 
(shortening) of  bent neurite in 
response to flow  of LPA-con- 
taining medium from micro- 
pipette.  Note  pear-shaped 
contours  of  LPA-containing 
medium  (also schematically 
illustrated in A). Bar, 40/~m. 
1992; Jalink et al., 1993). We sought to directly monitor the 
build-up of contractile forces in neurites using a new assay 
(see Materials and Methods). In this assay, the shaft of  a long 
neurite was mechanically detached from the dish and the 
"loose" part oftbe neurite was then subjected to a continuous 
flow of medium in such a manner as to bend it (Fig. 5). Ap- 
plication of medium containing either LPA or TRP causes 
rapid shortening of  the neurite, indicative of contractile force 
generation (Fig.  5).  Contraction of bent neurites was ob- 
served within rain after application of LPA (5 t~M) or TRP 
(250 #M) in every experiment (n =  14 and n  =  10, respec- 
tively). In contrast, after pretreating the cells with C3 (30 
#g/ml) for at least 3 h, LPA and TRP were no longer capable 
of shortening loose neurites (LPA, 8 nonresponders in 10 ex- 
periments carried out in five different cultures; P  <  0.002; 
TRP, 8 nonresponders in 9 experiments in three different cul- 
tures; P <  0.001). As expected, cells treated with the actin- 
disrupting agent cytochalasin D (5 pM) also fail to shorten 
their neurites in response to agonists. 
Aetin-based contractility in both muscle and nonmuscle 
cells is driven by the motor protein myosin. Normally, myo- 
sin  activity  is  regulated  by  myosin  light  chain  kinase 
(MLCK) and various other protein kinases and phosphatases 
(reviewed by Sellers, 1991). We used the selective MLCK in- 
hibitor KT5926 (Nakanishi et al., 1990) to test the possible 
involvement of  MLCK in the observed contractions. KT5926 
appears to be highly selective for MLCK when compared to 
other protein kinases tested (Nakanishi et al., 1990).  Treat- 
ment of serum-deprived N1E-115 cells with KT5926 blocks 
LPA-and  TRP-induced shape changes in a dose-dependent 
manner  (IC50 '~0.5  /~M; Fig.  6).  The  concentration  of 
KT5926 required for full inhibition (2-5 #M) is similar to 
the dose required to suppress MLC phosphorylation in intact 
platelets (Nakanishi et al., 1990).  These results suggest that 
the RheA-dependent contractile response to agonists in N1E- 
115 cells requires MLCK activity. 
Lack of Effect of C3 on Agonist-induced Ca  2÷ 
Mobilization and p21"*"  Activation 
We next tested whether C3 treatment affects other early re- 
sponses to LPA and thrombin. Both agonists evoke a rapid, 
phospholipase  C-mediated  Ca  2+  transient  in  their  target 
cells (Jalink et al., 1990, 1993; Jalink and Moolenaar, 1992). 
In cells pretreated with C3 (30/zg/ml for either 3, 24, or 96 
h), there were no detectable differences in shape and kinetics 
of the LPA- and TRP-induced Ca  2+ signal under conditions 
where  agonist-induced shape  changes  were  fully blocked 
(Fig. 7). 
Apart from phospholipase C  activation and subsequent 
Ca  2+ mobilization,  LPA,  and  thrombin  also  induce rapid 
activation of p21 ~  in a pertussis toxin-sensitive manner, at 
least in  fibroblasts (van  Corven et  al.,  1993).  In  serum- 
starved NIE-115  cells, basal p21"-GTP levels  were found 
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Figure 6. Effect of KT5926 on LPA-induced Shape Changes.  NIE- 
115 cells were treated  for 3 h with the indicated  concentrations of 
KT5926  (stock dissolved in DMSO), exposed to LPA (1 #M) for 
3  rain,  and the  ensuing  shape  change assessed  as described  in 
Materials and Methods. 
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Figure  7.  Effects  of C3  on  agonist-induced  Ca  2+  mobilization. 
Time course of changes in cytoplasmic free Ca  z+ induced by LPA 
and TRP in control and C3-pretreated NE-115 cells,  as indicated. 
(F) Ca2+-dependent indo-1 fluorescence.  For experimental  details 
see Materials  and Methods. 
Figure 8.  Effects  of C3 on the morphology of N1E-115 cells  in 
serum-containing medium. (A) Exponentially  growing cells in the 
presence of 10%  serum.  (B) Ceils treated with 30/~g/ml C3 for 
3 h in serum-containing medium. Note extensive flattening of cell 
bodies and formation of short neurite-like  extensions.  (C) Neurite 
formation in cells maintained  in 10% serum and 30 #g/ml C3 for 
4 d. At that time,  C3 was still active since C3-containing medium 
could be re-used several times to induce neurite outgrowth in other 
cultures.  Bar, 40 #m. 
to be as low as in quiescent normal fibroblasts,  i.e., around 
5% of total p21TM (van Corven et al.,  1993; and results not 
shown).  However, for unknown reasons,  LPA-induced p21TM 
activation was much more difficult to detect in N1E-115 cells 
than in fibroblasts. To examine whether ADP-ribosylation of 
Rho  might  affect  p21"-GTP  accumulation,  we  therefore 
turned to Rat-1  fibroblasts.  We verified that C3 (30/~g/ml, 
Jalink  et al. Rho and Receptor-mediated Neural Shape Changes  807 4 h pretreatment) fully inhibits LPA-induced stress fiber for- 
marion in these cells, as it does in 3T3 cells (Paterson et al., 
1990; Ridley and Hall, 1992; Jalink, J., unpublished obser- 
vations). We found that in C3-treated coils, LPA stimulates 
p21r--GTP accumulation to the same extent as in control 
cells (not shown). It thus appears that Rho function is re- 
quired  neither for agonist-induced Ca  2+  mobilization nor 
for p21 ~  activation. 
C3 Treatment Causes Cell Flattening and Neurite 
Outgrowth in the Presence of  Serum 
In the presence of 10% FCS, exponentially  growing NIE-115 
cells are round and refractile with neurite outgrowth being 
fully suppressed (Fig.  8 A; Jalink and Moolenaar,  1992). 
Given the inhibitory effect  of  C3 on cell rounding and neurite 
retraction in serum-starved cells, we reasoned that C3 treat- 
ment of rounded, undifferentiated cells maintained in 10% 
FCS might induce cell flattening  and morphological differen- 
tiation (i.e., the "serum-starved" phenotype). Indeed, cells 
treated for a few hours with C3 (30 #g/ml) in the presence 
of FCS become progressively more flattened, very similar to 
the phenotype induced by serum removal (Fig. 8 B; cf. Fig. 
2 A). Maximal cell flattening was observed after 24 h using 
30 #g/ml C3. Cell flattening was also induced by the MLCK 
inhibitor KT5926  in a  dose- and time-dependent manner 
(ECho ",~0.5 #M at 24-h pretreatment), suggesting that the 
phosphorylation state of myosin light chain is critical for 
maintaining the rounded, 'contracted' cell shape observed in 
serum-containing medium (not shown). 
Prolonged C3 treatment of NIE-115 cells for several days 
in the continuous presence of 10% FCS causes prominent 
neurite outgrowth accompanied by growth arrest (Fig. 8 C), 
again reminiscent of the differentiated  phenotype induced by 
long-term serum starvation. When C3-differentiated N1E- 
115 cells are exposed to LPA or thrombin, no shape changes 
were detectable even when monitored over a period of sev- 
eral hours (not shown). Treatment of PC12 cells with C3 for 
several days also results in neurite outgrowth and growth ar- 
rest (Nishiki et al.,  1990; Jalink, K., unpublished observa- 
tions); we found that the growth cones and neurites of C3- 
differentiated PC12 cells were completely resistant to LPA 
(not shown). 
Discussion 
The mechanisms by which neural cells regulate their com- 
plex morphology are poorly understood. Molecules as di- 
verse as extracellular matrix components, growth factors, 
neurotransmitters,  bioactive  phospholipids,  and  secreted 
proteases,  as well as  their inhibitors,  can exert dramatic 
effects on neural architecture, ranging from stimulation of 
neurite outgrowth to induction of growth cone collapse, neu- 
rite retraction,  and even neurodegeneration.  Rapid  with- 
drawal of developing neurites and their growth cones evoked 
by extracellular molecules is fundamental to nervous system 
development and neural plasticity.  Furthermore,  reversal 
and inhibition of neurite outgrowth is also of considerable 
clinical relevance: for example, axons in the central nervous 
system fail to regenerate after traumatic injury and this fail- 
ure might well be due to inhibitory factors formed at the sites 
of injury.  Several  studies point to  an important role  for 
thrombin and LPA in provoking neurite retraction and sup- 
pressing neural differentiation (Monard,  1988;  Jalink and 
Moolenaar,  1992;  Suidan et al.,  1992;  Tigyi and Miledi, 
1992;  Jalink et al.,  1993, and  references  therein).  Both 
thrombin and LPA are rapidly produced during injury and 
blood clotting, but they may also play a role in normal ner- 
vous system functioning. In cultures of primary neurons and 
neural cell lines, thrombin, LPA, and serum (which contains 
LPA) cause rapid retraction of developing neurites and, at 
least in neuroblastoma ceils, transient rounding of the cell 
soma.  Thrombin  and  LPA  act  through  their  cognate  G 
protein-coupled receptors  but the  ensuing morphological 
effects appear to be independent of known second messenger 
systems (Jalink and Moolenaar, 1992;  Suidan et al.,  1992; 
Jalink et al.,  1993). 
In this study we have used recombinant bacterial C3 ex- 
oenzyme to explore the possible role of the Rho small GTP- 
binding protein in the action of LPA and thromhin. The C3 
ADP-ribosyltransferase is very specific for Rho proteins and 
is at least two orders of magnitude less active on the closely 
related CDC42 and Rac proteins (Just et al.,  1991; Ridley 
and Hall,  1992).  We  show that C3  causes  in  situ ADP- 
ribosylation of the RhoA protein and thereby inhibits throm- 
bin- and LPA-induced neurite retraction and soma rounding 
in serum-starved NIE-115 cells; moreover, we found that C3 
treatment blocks LPA-induced neurite retraction in PC12 
cells. In particular, our analysis reveals that RhoA function 
is essential for the generation of contractile, actomyosin- 
based forces in the cortical cytoskeleton. Conversely, ADP- 
ribosylation of Rho in serum-exposed rounded cells causes 
cell flattening, probably as a result of reduced cytoskeletal 
tension, followed by prominent neurite outgrowth and growth 
arrest, very similar to what is observed after long-term se- 
rum starvation of N1E-115 cells. These findings suggest that 
RhoA functions in a receptor-linked signal transduction cas- 
cade that regulates actomyosin contractility which, in turn, 
controls both the retraction and outgrowth of neurites. 
A signaling role for RhoA in cytoskeletal organization was 
recently put forward by Hall and co-workers who showed 
that in serum-starved 3T3  cells, ADP-ribosylated Rho in- 
hibits  serum-  and LPA-induced formation of actin stress 
fibers and focal  adhesions,  whilst the  active GTP-bound 
form of RhoA promotes actin stress fiber formation (Pater- 
son et al.,  1990;  Ridley and Hall,  1992).  Although ADP- 
ribosylation of Rho causes flattened fibroblasts to round up 
with loss of attachment (Chardin et al.,  1989;  Paterson et 
al., 1990), just opposite to what is observed in N1E-115 cells 
(Figs. 2 and 8), our results are not necessarily incompatible 
with  the  fibroblast  model,  in  which  LPA  triggers  Rho- 
dependent formation of stress fibers. It is known that actin 
stress fibers are under a state of isometric contraction and 
that this contraction contributes to their formation (Bur- 
ridge,  1981); moreover,  serum  stimulation  of quiescent 
fibroblasts causes stress fibers to contract (Giuliano et al., 
1992). On the other hand, the present results are not readily 
compatible with LPA promoting cell-substratum adhesion, 
as occurs in serum-starved fibroblasts due to Rho-dependent 
focal adhesion assembly (Ridley and Hall,  1992). 
In platelets, ADP-ribosylation of RhoA inhibits thrombin- 
induced aggregation (Morii et al., 1992); and in a B cell line, 
ADP-ribosylation of RhoA prevents phorbol ester-induced 
cell aggregation, apparently by affecting the process of inte- 
grin "activation" rather than interfering with actin polymer- 
ization (Tominaga et al., 1993). In the latter cell types, RhoA 
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kinase  C-signaling  pathway. In  neuronal  ceils,  however, 
agonist-induced  neurite  retraction  and  cell  rounding  are 
causally unrelated to the phospholipase C/Ca2+/protein ki- 
nase C cascade (Jalink and Moolenaar,  1992; Jalink et at., 
1993), which strongly argues against a role for RhoA in this 
classic second messenger system. Instead, the available evi- 
dence supports a model in which LPA and thrombin trigger 
at least three separate signaling  pathways involving activa- 
tion  of phospholipase  C,  I>21TM and  I>21  rb°, respectively. 
Cross-talk between Ras- and Rho-dependent signaling path- 
ways has recently been proposed (Settlernan  et at.,  1992). 
How may RhoA function in neurite retraction and,  when 
ADP-ribosylated, promote neurite outgrowth? RhoA-depen- 
dent contractility  is abolished by a  selective  inhibitor  of 
MLCK,  KT5926,  suggesting  a  critical  role for the phos- 
phorylation  state of myosin light  chain.  Interestingly,  in- 
creased myosin phosphorylation accompanies the contrac- 
tion of actin  stress fibers in  serum-stimulated  fibroblasts 
(Giuliano et at.,  1992). In astrocytes, a decrease in myosin 
light chain phosphorylation (by KT5926) has been suggested 
to cause destabilization  of the cortical actin  cytoskeleton 
which, in turn, promotes process outgrowth  (Baorto et at., 
1992).  But perhaps  the most appealing  analogy  emerges 
from smooth muscle physiology. In smooth muscle, several 
agonists can increase G-protein-mediated MLC phosphory- 
lation  and  contractile  force  at  constant  cytosolic  [Ca  2+] 
(Kitazawa et at., 1991). ADP-ribosylated RhoA was reported 
to block GTP-induced enhancement of smooth muscle con- 
traction  and active RhoA.GTP could overcome this inhibi- 
tion (Hirata et at., 1992). Taken together, the results suggest 
that RhoA and its putative downstream effector(s) somehow 
regulate receptor-linked actomyosin contractility indepen- 
dently of prior Ca2+-mobilization, possibly by altering  the 
balance between MLC kinase and phosphatase activity (of. 
Kitazawa et at.,  1991), and thereby direct neurite behavior. 
Our preliminary results indicate that LPA-induced neuronal 
shape changes are accompanied by enhanced phosphorylation 
ofa 20-kD protein with a pI close to that of  the 20-kD myosin 
light chain (Eichholtz,  T., and W. H. Moolenaar,  data not 
shown).  Thus,  the available  evidence supports a model in 
which basal Rho activity is necessary to maintain actomyosin- 
based neurite tension and cell shape; increased Rho activity 
(Rho-GTP accumulation)  then triggers  neurite contraction, 
whereas inactive (ADP-ribosylated) Rho somehow shuts off 
the contractile function of the cortical actomyosin system 
and thereby promotes neurite outgrowth.  Direct biochemical 
studies should help to unravel the Rho-dependent events that 
control aetomyosin contractility  in neural cells. 
Since RhoA in N1E-115 cells apparently does not function 
in one of the classic signal transduction pathways, it is tempt- 
ing to speculate that RhoA is activated by LPA and thrombin 
in a manner similar  to that proposed for p21 ~  activation, 
i.e.,  through  a putative,  intermediate  tyrosine kinase (van 
Corven et al., 1993). Indeed, not only are the morphological 
actions of LPA and thrombin blocked by protein tyrosine ki- 
nase inhibitors,  neurite retraction and cell rounding are also 
accompanied by a rapid increase in p60  '~ tyrosine kinase 
activity (Jalink and Moolenaar,  1992; Jalink et at.,  1993). 
On the other hand, recent results  suggest that in 3T3 cells 
Rho is essential to couple the LPA receptor to enhanced pro- 
tein  tyrosine kinase activity (Kumagai  et ai.,  1993).  The 
putative link between tyrosine kinase activation,  RhoA rune- 
tion,  and  actomyosin  contractility  should be  explored in  fur- 
thcr  biochemical studies.  Although  a  signaling  role  for  RhoA 
in linking  the receptors  for LPA and thrombin to the ac- 
tomyosin  system is  supported  by  the  available  data,  it  should 
be emphasized  that our results  do not eliminate  the formal 
possibility that ADP-ribosylated Rho causes subtle modifi- 
cations in the actomyosin system and thereby prevents it from 
proper functioning.  Determination of the relative levels of 
guanine  nucleotides  bound to RhoA and microinjection of 
active RhoA.GTP will help to distinguish between these pos- 
sibilities. 
In  conclusion,  the present results  add a  new aspect of 
RhoA function to the rapidly expanding  list of Rho-depen- 
dent cytoskeletal events in that we have identified  RhoA as 
an essential  component in the control of actin-based forces 
and neuronal  cell shape  by LPA and thrombin.  How the 
receptors for LPA and thrombin couple to RhoA-dependent 
actomyosin  contractility  and  thereby  regulate  neural  ar- 
chitecture  is a major challenge  for future experiments. 
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